Stockscreener 앱 받기
0.2908
0.28%
0.0008
시간 외 거래:
.29
-0.0008
-0.28%
전일 마감가:
$0.29
열려 있는:
$0.31
하루 거래량:
525.40K
Relative Volume:
3.08
시가총액:
$15.20M
수익:
$30.31M
순이익/손실:
$-22.84M
주가수익비율:
-0.6462
EPS:
-0.45
순현금흐름:
$-22.61M
1주 성능:
-21.41%
1개월 성능:
-37.33%
6개월 성능:
-74.27%
1년 성능:
-76.92%
1일 변동 폭
$0.2612
$0.3289
1주일 범위
$0.252
$0.36
52주 변동 폭
$0.252
$1.28
Enzo Biochem Inc Stock (ENZ) Company Profile
명칭
Enzo Biochem Inc
전화
(516) 755-5500
주소
60 EXECUTIVE BLVD, FARMINGDALE, NY
ENZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENZ
Enzo Biochem Inc
|
0.2908 | 15.20M | 30.31M | -22.84M | -22.61M | -0.45 |
|
TMO
Thermo Fisher Scientific Inc
|
437.87 | 165.21B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
180.62 | 130.05B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
378.99 | 31.91B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
103.59 | 29.01B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.01 | 27.28B | 15.41B | 1.37B | 2.11B | 7.50 |
Enzo Biochem Inc Stock (ENZ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2011-10-18 | 재확인 | Rodman & Renshaw | Mkt Outperform |
| 2009-09-23 | 개시 | Rodman & Renshaw | Mkt Outperform |
| 2007-09-13 | 개시 | Lazard Capital | Buy |
Enzo Biochem Inc 주식(ENZ)의 최신 뉴스
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Virtu Financial LLC Takes $35,000 Position in Enzo Biochem, Inc. (NYSE:ENZ) - Defense World
Enzo Biochem stock hits 52-week low at $0.33 amid market challenges By Investing.com - Investing.com South Africa
Enzo Biochem to Delist from NYSE, Move to OTCQX - TipRanks
Enzo Biochem stock hits 52-week low at $0.33 amid market challenges - Investing.com Australia
StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem to delist from NYSE, move to OTCQX market By Investing.com - Investing.com South Africa
Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall - MSN
Enzo Biochem to delist from NYSE, move to OTCQX market - Investing.com India
Enzo Biochem (ENZ) to Voluntarily Delist from NYSE, Move to OTCQ - GuruFocus
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX - The Manila Times
Enzo Biochem Announces Notification to New York Stock - GlobeNewswire
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily - Bluefield Daily Telegraph
NYSE Delisting Alert: Enzo Biochem Moving to OTCQXWhat Shareholders Must Know - Stock Titan
Here’s Why Enzo Biochem (ENZ) Declined in Q4 - Yahoo Finance
ENZ Stock Down Following Q2 Earnings, Revenues Decline Y/Y - Nasdaq
Enzo Biochem Inc (ENZ) Reports Q2 Fiscal 2025 Revenue of $7.3 Mi - GuruFocus.com
Enzo Biochem: Fiscal Q2 Earnings Snapshot - The Pioneer
Enzo Biochem Reports Decline in Quarterly Revenues - TipRanks
Enzo Biochem Inc. ($0.01 Par Value) (ENZ) reports earnings - Quartz
Enzo Biochem Stages Comeback: Q2 Shows 18% Growth, Key Segment Returns to Profit - StockTitan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Enzo Biochem: Fiscal Q2 Earnings Snapshot -March 17, 2025 at 04:30 pm EDT - Marketscreener.com
ENZO BIOCHEM INC SEC 10-Q Report - TradingView
Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results - GlobeNewswire
Protein Stability Analysis Market Future Business - openPR
Enzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.com - Defense World
Enzo Biochem, Inc. to Host Earnings Call - ACCESS Newswire
Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - The AM Reporter
Protein Stability Analysis Market Generated Opportunities, - openPR
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - Defense World
Enzo Biochem, Inc.'s (NYSE:ENZ) 28% Share Price Plunge Could Signal Some Risk - Simply Wall St
Enzo Biochem stock hits 52-week low at $0.51 amid challenges - MSN
ENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024 - MSN
Neuroscience Antibodies and Assays Market to Grow by USD 2.20 Billion from 2024-2028, Rising Neurological Disorders Boost Growth, Report on How AI is Redefining Market LandscapeTechnavio - The Malaysian Reserve
NYAG’s Enforcement of Mandated Cybersecurity Safeguards Sends Expensive Shock Waves through Varying Industries - Law.com
Enzo Biochem Inc (ENZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
0.67%
자본화:
|
볼륨(24시간):